Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005
2009
The Increase in Thyroid Cancer Incidence During the Last Four Decades Is Accompanied by a High Frequency of BRAF Mutations and a Sharp Increase in RAS Mutations
2013
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
2013 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Ageing populations: the challenges ahead
2009 Standout
The changing incidence of thyroid cancer
2016
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
2003 StandoutNobel
The relationship between prognostic and predictive factors in the management of breast cancer
1998
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data
2020
Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial
2010
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
2008
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
The prevalence and outcomes of frailty in older cancer patients: a systematic review
2014
The role of cancer registries in cancer control
2008
Thyroid cancer incidence trends by histology in 25 countries: a population-based study
2021
A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer
1996
Pancreatic cancer
2004 Standout
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)
2001
Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
2013
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Thyroid cancer
2016 Standout
Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data
2006
Global Cancer Statistics, 2002
2005 Standout
Pancreatic cancer
2020 Standout
Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population
2008
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Cancer Statistics, 2006
2006 Standout
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Pathways to the diagnosis of thyroid cancer in New South Wales: a population-based cross-sectional study
2011
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Estimates of the world‐wide prevalence of cancer for 25 sites in the adult population
2001
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
2012
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
2004
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Colorectal cancer
2013 Standout
Epidemiology and long term survival of gastric carcinoma in the French district of Finistère between 1984 and 1995
2005
International patterns and trends in thyroid cancer incidence, 1973–2002
2008
Pancreatic Adenocarcinoma
2014 Standout
Global cancer statistics
2011 Standout
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
2003
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
The evolution of the population-based cancer registry
2006
Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology
2010
Cancer prevalence in European registry areas
2002
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
2005
Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer— is there a need for radioactive iodine therapy?
2012
GEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma
2011
Frailty: implications for clinical practice and public health
2019 Standout
Second Malignant Neoplasms in Digestive Organs After Childhood Cancer: A Cohort-Nested Case-Control Study
2012
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients
2012
Adjuvant therapy in pancreatic cancer: historical and current perspectives
2003
International trends in prostate-cancer mortality in the ?PSA era?
2001
How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?
2010
Pancreatic Cancer
2010 Standout
EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
2009
Differences in postoperative outcomes, function, and cosmesis: open versus robotic thyroidectomy
2010
The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients
1994
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
2014
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
2010 Standout
Advances in diagnostic practices affect thyroid cancer incidence in France
2004
Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors
2012
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective
2004
Molecular genetics and diagnosis of thyroid cancer
2011
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE study
2011
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
2008
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease
2007
Breast cancer metastasis: markers and models
2005 Standout
Pancreatic cancer
2011 Standout
Thyroglobulin in the Washout Fluid of Lymph-Node Biopsy: What Is Its Role in the Follow-Up of Differentiated Thyroid Carcinoma?
2013
Second Primary Malignancy Risk in Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis
2007
Thyroid Cancer in Childhood: A Retrospective Review of Childhood Course
2010
The Increasing Incidence of Thyroid Cancer: The Influence of Access to Care
2013
Gemcitabine Combined With Oxaliplatin in Advanced Pancreatic Adenocarcinoma: Final Results of a GERCOR Multicenter Phase II Study
2002
Older Female Cancer Patients: Importance, Causes, and Consequences of Undertreatment
2007
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Thyroid cancer “epidemic” also occurs in low‐ and middle‐income countries
2018
Cancer statistics in China, 2015
2016 Standout
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
2013 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.
2003
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer.
2003
Thyroid Cancer Incidence in India Between 2006 and 2014 and Impact of Overdiagnosis
2020
Cancer incidence, survival and mortality: Explaining the concepts
2014
Global cancer statistics, 2012
2015 Standout
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies
2007
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
2014 Standout
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
Works of Marc Colonna being referenced
Prognostic value of epidermal growth factor receptor in a series of 303 breast cancers
1992
Ten-year survival and risk of relapse for testicular cancer: A EUROCARE high resolution study
2007
A recent increase in the incidence of prostatic carcinoma in a French population: Role of ultrasonography and prostatic specific antigen
1995
Éléments d’interprétation des estimations régionales de l’incidence du cancer en France sur la période 1980–2005
2008
Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France
2015
A time trend analysis of papillary and follicular cancers as a function of tumour size: A study of data from six cancer registries in France (1983–2000)
2007
Survival of women with breast cancer in France: variation with age, stage and treatment
2001
Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma
2005
Descriptive epidemiology of thyroid cancer in France: Incidence, mortality and survival
2009
Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study
2000
Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge database
2007
Cancer prevalence in France: Time trend, situation in 2002 and extrapolation to 2012
2007
Lack of prognostic value of epidermal growth factor receptor in a series of 229 T1/T2, N0/N1 breast cancers, with well defined prognostic parameters
1994
The cancer survival gap between elderly and middle-aged patients in Europe is widening
2009
Bootstrap Investigation of the Stability of Disease Mapping of Bayesian Cancer Relative Risk Estimations
2004
Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997)
2002
Estimation of colorectal cancer prevalence in France
2001
Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries
2010
Measuring cancer prevalence in Europe: the EUROPREVAL Project
2002
The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases
2023
S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
2001
Variation in relative survival of thyroid cancers in Europe: Results from the analysis on 21 countries over the period 1983–1994 (EUROCARE-3 study)
2006
[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer: multicentric retrospective study II. DNA-ploidy and S-phase fraction].
1999
[Estimation of the incidence of digestive tract cancers by region].
1999
[Empirical Bayes estimates of relative risk: principles and examples].
1997